The Enrico Fermi Research Center - CREF promotes original and high-impact lines of research, based on physical methods, but with a strong interdisciplinary character and in relation to the main problems of the modern knowledge society.
The CREF was born with a dual soul: a research centre and a historical museum. Its aim is to preserve and disseminate the memory of Enrico Fermi and to promote the dissemination and communication of scientific culture.
Publications, news, press review. For interviews, filming, and press contacts, please write to comunicazione@cref.it
The NQN (Quantitative Neuroscience and Neuroimaging) project is dedicated to exploring the dynamics of brain function through a combined approach of quantitative magnetic resonance imaging (MRI) and advanced computational models. Our research focuses on how information processing at the cerebral cortex level is linked to the energy consumption that supports it and the microstructural substrate that enables its transmission. We study both the brain’s spontaneous functional fluctuations and those induced by interaction with the external environment.
We constantly innovate MRI technologies to achieve these goals and develop new multimodal analysis methodologies. This project has a strong interdisciplinary focus and aims to contribute to developing advanced diagnostic tools for the characterization, diagnosis, and treatment of neurological and psychiatric disorders.
Functional MRI (fMRI) leverages changes in blood flow and oxygenation to map brain activity.
When a region of the brain is active, it requires a greater supply of oxygen, which causes an increase in blood flow to that area. fMRI detects these changes, allowing us to identify the brain regions involved in specific cognitive and behavioral functions. Magnetic resonance imaging not only visualizes brain structures with very high spatial resolution but also allows us to study the functional connectivity between different brain regions.
Diffusion MRI (dMRI) techniques allow us to trace the structures of white matter, revealing the structural substrate of long-range connections between distant brain areas and contributing to our understanding of how information is integrated in the brain.
Furthermore, metabolic and biochemical aspects of the brain can be studied through magnetic resonance spectroscopy (MRS). This approach provides information on the metabolites present in brain tissue, offering a unique window into the biochemical processes that occur in both healthy and diseased brains.
Thanks to the continuous evolution of imaging technologies, we can address increasingly complex questions, moving closer to understanding the fundamental mechanisms that govern brain function. These advancements not only improve our basic knowledge of the brain but also have important clinical implications, contributing to the development of new treatments and interventions for a wide range of neurological and psychiatric disorders, ultimately improving the quality of life.
The project has two main goals: to understand the link between metabolism and brain function and to use this knowledge to characterize certain neurodegenerative diseases.
Our methodological activities are aimed at optimizing microstructural and functional MRI techniques (in terms of acquisition, processing pipelines, and noise mitigation), as well as developing appropriate tools for the quantitative interpretation of results (biophysical modeling and computational approaches).
Our applied activities are focused on characterizing cerebral physiology, with particular attention to the dynamics of brain function, its modulations related to disease and physiological aging, and the microstructural and metabolic substrate of functional alteration.
Over the next three years, these goals will be pursued through several intermediate objectives:
Developing MRI technologies for quantitative measurements of metabolic dynamics, oxygen consumption, and vascular reactivity; applying these to the study of brain energetics.
Developing heteronuclear imaging with 23Na to investigate early functional alterations in Alzheimer’s disease (AD).
Characterizing the dynamics of brain networks and identifying components of non-neuronal origin.
Developing spinal cord imaging.
Characterizing the architecture of white matter connections and their microstructural properties to study progressive changes in the onset of Alzheimer’s disease.
This project has a potentially very significant impact on people’s health and well-being. The development of our MRI-based techniques can lead to a better understanding of the biological mechanisms underlying diseases that are devastating to both individuals and society. Furthermore, the identification and validation of new biomarkers for neurological pathologies can enable earlier diagnosis, which in turn can improve the prospects for effective treatment. Finally, the quantitative techniques we develop can be used to characterize the effectiveness of new drugs and treatments with greater accuracy and less bias, indirectly contributing to their development.
We have fine-tuned the method for measuring cerebrovascular reactivity (CVR) and are currently acquiring data from Alzheimer’s patients. Over the next three years, we’ll first verify whether CVR provides useful insights into neurodegenerative processes. In a second phase, we will further develop the CVR measurement method to derive quantitative measures of cerebral metabolic rate of oxygen (CMRO2).
CMRO2 measurements will be combined with spectroscopy measurements to characterize the energetics of perception. We recently showed that visual perception induces a decoupling between the functional and metabolic responses; we aim to verify if this decoupling is linked to a different regulation of aerobic metabolism. This would have important consequences for interpreting functional data and understanding pathologies or conditions that impact perception (e.g., hallucinatory states). We also plan to study the association between metabolic modulations and the dynamics of the BOLD signal, which is a potential biomarker for numerous diseases.
This section was funded by the Lazio Region (FISASMEM project) and is partially funded by a PRIN-PNRR project (MUR PRIN 2022 P202294JHK “RECENTRE”).
We have recently developed MRI techniques based on 23Na imaging to identify potential biomarkers in AD and explore the pathophysiological processes behind microstructural tissue damage and cognitive decline. Sodium homeostasis is associated with neuroinflammation, with potential sensitivity to vascular and metabolic alterations. The methodological development has been completed, and data acquisition is underway, set to be finalized during the year. Using this data, we will test the association between sodium metrics, inflammatory/neurodegenerative processes, and cognitive dysfunction in AD to characterize the usefulness of 23Na metrics as biomarkers.
This section is currently funded by the PNRR through a synergistic project at the Santa Lucia Foundation (PNRR MAD-2022-12376889).
Connectome analysis techniques are based on assessing data covariance structure and are highly sensitive to coherent spurious signals, including “physiological noise” (i.e., variations induced by physiological rhythms like breathing, movement, or heartbeat). In the near future, we will finalize our study on noise mitigation in high-resolution functional connectivity. Functional connectivity between cortical layers has the potential to evaluate the directionality of connections, distinguish input and output activity, and more directly investigate the function of microcircuits. However, the quality of high-resolution fMRI data is strongly degraded by noise. We have developed a denoising approach that combines spatial realignment of fMRI volumes, thermal denoising, and methods for mitigating physiological noise. Our results show a different effect of various noise components in cortical layers and a corresponding modulation of spurious intracortical connectivity.
Starting in 2025, this section will be substantially expanded, also converging with the “Development of MRI Technologies” section. We aim to provide a complete characterization of the functional aspects of pial vein dynamics in terms of their salient features, transients, and frequency composition. The goal is to push the limits of functional MRI at 3 Tesla up to 1 mm3, improve thermal and physiological denoising techniques, and provide new biomarkers for cerebrovascular health. The behavior of pial veins will be modulated in the experimental phase by administering simple functional tasks of different durations and types, while the vessels’ baseline state will be modulated through mild hypercapnia and hyperoxia. We will extract physiological and metabolic indicators as a function of the cortical layer from fMRI data and separate the vascular component. We will combine consolidated imaging methods (gradient-echo BOLD) with less conventional contrasts (VASO, or Vascular Space Occupancy for blood volume mapping, and pCASL for blood flow) and different experimental conditions (hyperoxia, hypercapnia, visual tasks, rest state). The respiratory challenges will allow for the calibration of the MRI signal and thus enable us to estimate CMRO2 variations in different cortical layers. However, since the fMRI signal at a certain depth does not necessarily reflect the activity of a single layer, it is essential to consider the cortical circuitry and the task-specific metabolic demand. To this end, we will use a consolidated cortical model, which incorporates non-linear synaptic plasticity, to predict the expected profile of CMRO2 variations during visual tasks, comparing it with the acquired fMRI data.
While the small size of the voxels will cause high thermal noise, which does not depend on cortical depth, physiological noise has a significant contribution in the upper layers. We will continue to optimize denoising to maximize noise uniformity within the gray matter and reduce spurious connectivity, which our results suggest primarily affects the upper layers. In the continuation of this study, we will verify if these denoising techniques allow for high-resolution fMRI at a clinical field strength (3 T) with acquisition times compatible with patient use. The duration of this project section is estimated at three years.
This section is currently funded by the PNRR through project M4 C2, “MNESYS SINVASC.”
Although clinical MRI of the spinal cord is commonly used, it has so far proven unable to provide reliable quantitative metrics for a comprehensive characterization of tissue damage. In this context, we have optimized an experimental protocol and data analysis pipeline for the spinal cord to study patients with traumatic and inflammatory spinal cord injuries, both at the cervical and dorsal levels. We are currently applying the optimized protocol to healthy subjects and patients with cervical or dorsal lesions. To characterize the extent of the damage and predict clinical outcomes, lesion segmentation is a necessary step, which we are now refining. Lesion segmentation will allow for a precise localization of the damage, enabling the local calculation of advanced morphometric measures.
This section is currently funded by the PNRR with a synergistic project at the Santa Lucia Foundation (MCNT2-2023-12378303).
The white matter tracts in the human brain form the fundamental substrate for the integration of different gray matter areas and create a true infrastructure that underpins brain function. Damage to these tracts, whether localized in circumscribed areas (lesions) or diffused throughout entire anatomical structures, is central to the pathophysiology of numerous neurological diseases. Diffusion MRI makes it possible not only to reconstruct the short- and long-range connections that form the brain’s network but also to characterize the microscopic properties of the related tissues through compartmental models that rely on an extensive use of diffusion gradients.
Over the next three years, we will characterize the macro- and microstructure of white matter in different patient cohorts that cover a large part of the cognitive deficit spectrum: patients with subjective cognitive decline, those with mild cognitive impairment, and finally those affected by AD. This study will explore, in parallel, the onset and characterization of lesions and the localized differences in white matter structures associated with cognitive functions of interest.
Nazionali
Internazionali:
Thomas Beyer et al. “Medical Physics and Imaging – A timely perspective”. Frontiers in Physics 9 (2021), 634693. doi: 10.3389/fphy.2021.634693.